Home
/
Rani Therapeutics Holdings, Inc.
/
Financials
/
Quarterly
Rani Therapeutics Holdings, Inc. — Quarterly Financials
Quarterly figures from SEC EDGAR XBRL filings (10-Q)
These figures are extracted from XBRL-tagged quarterly reports (10-Q) that Rani Therapeutics Holdings, Inc. filed with the SEC. Values are as reported for each individual quarter (Q1, Q2, Q3, Q4) — not cumulative year-to-date. Negative figures indicate a loss.
Revenue — By Quarter
Quarter
Fiscal Year
Period End
Value
Filed
Q3
2025
Sep 30, 2025
$0
Nov 6, 2025
Q2
2025
Jun 30, 2025
$0
Aug 7, 2025
Q1
2025
Mar 31, 2025
$172.0K
May 13, 2025
Q3
2025
Sep 30, 2024
$0
Nov 6, 2025
Q2
2025
Jun 30, 2024
$0
Aug 7, 2025
Q1
2025
Mar 31, 2024
$0
May 13, 2025
Q3
2022
Sep 30, 2022
$0
Nov 10, 2022
Q2
2022
Jun 30, 2022
$0
Aug 10, 2022
Q3
2022
Sep 30, 2021
$0
Nov 10, 2022
Q2
2022
Jun 30, 2021
$1.96M
Aug 10, 2022
Q1
2022
Mar 31, 2021
$756.0K
May 11, 2022
Q3
2021
Sep 30, 2020
$108.0K
Nov 16, 2021
Q2
2021
Jun 30, 2020
$60.0K
Sep 13, 2021
Net Income — By Quarter
Quarter
Fiscal Year
Period End
Value
Filed
Q3
2025
Sep 30, 2025
($5.41M)
Nov 6, 2025
Q2
2025
Jun 30, 2025
($6.69M)
Aug 7, 2025
Q1
2025
Mar 31, 2025
($7.26M)
May 13, 2025
Q3
2025
Sep 30, 2024
($6.78M)
Nov 6, 2025
Q2
2025
Jun 30, 2024
($6.81M)
Aug 7, 2025
Q1
2025
Mar 31, 2024
($7.48M)
May 13, 2025
Q3
2024
Sep 30, 2023
($9.20M)
Nov 14, 2024
Q2
2024
Jun 30, 2023
($9.30M)
Aug 6, 2024
Q1
2024
Mar 31, 2023
($8.37M)
May 6, 2024
Q3
2023
Sep 30, 2022
($7.96M)
Nov 8, 2023
Q2
2023
Jun 30, 2022
($7.62M)
Aug 11, 2023
Q1
2023
Mar 31, 2022
($6.22M)
May 10, 2023
Q3
2022
Sep 30, 2021
($3.14M)
Nov 10, 2022
Q2
2021
Jun 30, 2021
($5.49M)
Sep 13, 2021
Q2
2021
Mar 31, 2021
($5.60M)
Sep 13, 2021
Q3
2021
Sep 30, 2020
($2.88M)
Nov 16, 2021
Q2
2021
Jun 30, 2020
($2.71M)
Sep 13, 2021
Q3
2021
Jun 30, 2020
($2.71M)
Nov 16, 2021
Q3
2021
Mar 31, 2020
($5.35M)
Nov 16, 2021
Q2
2021
Mar 31, 2020
($5.35M)
Sep 13, 2021
Operating Income — By Quarter
Quarter
Fiscal Year
Period End
Value
Filed
Q3
2025
Sep 30, 2025
($7.26M)
Nov 6, 2025
Q2
2025
Jun 30, 2025
($10.51M)
Aug 7, 2025
Q1
2025
Mar 31, 2025
($12.01M)
May 13, 2025
Q3
2025
Sep 30, 2024
($11.80M)
Nov 6, 2025
Q2
2025
Jun 30, 2024
($12.52M)
Aug 7, 2025
Q1
2025
Mar 31, 2024
($14.03M)
May 13, 2025
Q3
2024
Sep 30, 2023
($17.86M)
Nov 14, 2024
Q2
2024
Jun 30, 2023
($18.29M)
Aug 6, 2024
Q1
2024
Mar 31, 2023
($16.52M)
May 6, 2024
Q3
2023
Sep 30, 2022
($16.34M)
Nov 8, 2023
Q2
2023
Jun 30, 2022
($15.85M)
Aug 11, 2023
Q1
2023
Mar 31, 2022
($13.78M)
May 10, 2023
Q3
2022
Sep 30, 2021
($27.78M)
Nov 10, 2022
Q2
2022
Jun 30, 2021
($5.26M)
Aug 10, 2022
Q1
2022
Mar 31, 2021
($5.20M)
May 11, 2022
Q3
2021
Sep 30, 2020
($2.83M)
Nov 16, 2021
Q2
2021
Jun 30, 2020
($3.39M)
Sep 13, 2021